Loteprednol
- Generic Name
- Loteprednol
- Brand Names
- Alrex, Lotemax, Zylet
- Drug Type
- Small Molecule
- Chemical Formula
- C21H27ClO5
- CAS Number
- 129260-79-3
- Unique Ingredient Identifier
- Z8CBU6KR16
- Indication
用于眼科局部炎症。0.2％浓度适用于暂时缓解季节性过敏性结膜炎；0.5％混悬液适用于治疗对类固醇有效的炎症，如结膜炎、角膜、前房炎、过敏性结膜炎、痤疮、酒糟鼻、表浅性点状角膜炎、疱疹、带状疱疹角膜炎、虹膜炎、睫状体炎等可适当减轻水肿和炎症。尚可用于眼科手术后炎症的治疗。
- Associated Conditions
- Chickenpox, Conjunctivitis infective, Cyclitis, Eye infection viral, Herpes Zoster Keratitis, Inflammation, Iritis, Ocular Inflammation, Rosacea, Seasonal Allergic Conjunctivitis, Superficial punctate keratitis
Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation
Phase 4
Completed
- Conditions
- Cataract Extraction
- First Posted Date
- 2006-08-21
- Last Posted Date
- 2018-06-14
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 40
- Registration Number
- NCT00366691
- Locations
- 🇺🇸
Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath